NCT01116089 Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer Status COMPLETED Phase PHASE1
NCT01112059 Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients Status COMPLETED Phase NA
NCT01111383 A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® Status COMPLETED Phase PHASE3
NCT01100606 A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age Status COMPLETED Phase PHASE4
NCT01094704 Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT01093521 A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients Status COMPLETED Phase PHASE1
NCT01090908 Evaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P. Aeruginosa Status WITHDRAWN Phase N/A
NCT01086839 Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis Status COMPLETED Phase NA
NCT01078740 Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects Status COMPLETED Phase N/A
NCT01072721 Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis Status COMPLETED Phase NA
NCT01060566 Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770 Status COMPLETED Phase PHASE1
NCT01059565 Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection Status COMPLETED Phase PHASE3
NCT01055847 Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection Status COMPLETED Phase PHASE2